Is it a rock, or is it Jell-O? Defining the architecture of rhomboid enzymes

Jul 31, 2012
Is it A rock, or is it jell-O? Defining the architecture of rhomboid enzymes
Molecular structure of the rhomboid enzyme.

(Phys.org) -- Johns Hopkins scientists have decoded for the first time the “stability blueprint” of an enzyme that resides in a cell’s membrane, mapping which parts of the enzyme are important for its shape and function. These studies, published in advance online on June 14 in Structure and on July 15 in Nature Chemical Biology, could eventually lead to the development of drugs to treat malaria and other parasitic diseases. 

“[It’s] the first time we really understand the architectural logic behind the structure of the enzyme,” says Sinisa Urban, Ph.D., an associate professor of molecular biology and genetics at the Johns Hopkins University School of Medicine and an investigator at the Howard Hughes Medical Institute, who with his team has unlocked the mysteries of a special class of enzymes called rhomboid proteases.

Is it A rock, or is it jell-O? Defining the architecture of rhomboid enzymes
Molecular structure of the rhomboid enzyme.

Rhomboid proteases are present in many different organisms, and are a unique type of enzyme that resides in the cell’s membrane where they cut proteins. Previously Urban and his colleagues demonstrated that the rhomboid enzyme is critical for Plasmodium falciparum, the parasite that causes malaria, to successfully invade red blood cells, a step that ultimately leads to infection. Urban says understanding the stability of rhomboid protease shape may impact the design of enzyme inhibitors – potential drugs. “These enzymes have no selective inhibitors,” says Urban. “We really need to understand how [the enzyme] works – is it as stiff as a rock, or is it more gummy, like Jell-O?” 

One challenge of studying rhomboid enzymes is that they are surrounded by membranes, making them more difficult to manipulate and work with. To address this, Urban’s research team turned to a technique known as thermal light scattering, which heats enzyme samples to progressively higher temperatures while measuring the amount of light bouncing back off of the molecules. Enzymes that have broken from their normal shape will scatter light differently, and the temperature at which this occurs (in effect, the breaking point of the enzyme) indicates the inherent stability of the enzyme.

The researchers first precisely measured the stability of the rhomboid enzyme from E. coli bacteria. Surprisingly, says Urban, the rhomboid enzyme was more “Jell-O-like” than other membrane proteins with similar shapes. He guesses that this “jiggly shape” may help rhomboid proteases interact with other proteins that it cuts. To find which parts of the enzyme are most important for maintaining shape and which parts are more crucial for function, the researchers then made and tested 150 differently altered versions of the enzyme. They found four main regions important for maintaining shape and at least two regions important for function.

The researchers also took advantage of computer simulations to test their ideas about how the enzyme functions. Using a computer program model of the enzyme, they programmed in features of its natural membrane environment, which consists mostly of fats and is very limited in water. The computer program then simulated how this environment might influence the enzyme. Researchers found that the enzyme contains a special internal pocket for holding water molecules – a great advantage in its natural, water-limiting environment. 

“We’re very excited about our findings and are especially curious about the versions of the that lost function despite no obvious change in stability or shape,” says Urban. Ultimately he hopes that a better understanding of rhomboid proteases will lead to new therapies for treating malaria and other parasitic diseases.

Explore further: Cell research: enzyme questions important principle of evolution

Related Stories

How Montezuma gets his revenge

Jun 15, 2008

Every year, about 500 million people worldwide are infected with the parasite that causes dysentery, a global medical burden that among infectious diseases is second only to malaria. In a new study appearing in the June 15 ...

Form and function in enzyme activity

Apr 06, 2012

Many industrial chemistry applications, such as drug or biofuel synthesis, require large energy inputs and often produce toxic pollutants. But chemistry and chemical biology professor Mary Jo Ondrechen said ...

New protein structure model to inhibit cancer

Jul 29, 2011

Researchers at the University of Hertfordshire have developed a new structural model of a protein, which makes it possible to develop more effective drugs to target diseases such as cancer, heart disease and influenza.

Recommended for you

New method for producing clean hydrogen

9 hours ago

Duke University engineers have developed a novel method for producing clean hydrogen, which could prove essential to weaning society off of fossil fuels and their environmental implications.

Making ice-cream more nutritious with meat left-overs

16 hours ago

Food industries are now turning meat left-over into high-protein content ingredients for food supplements, or to be added to processed food. But a EU-wide regulation covering them is still lacking.

Non-wetting fabric drains sweat

May 20, 2013

(Phys.org) —Waterproof fabrics that whisk away sweat could be the latest application of microfluidic technology developed by bioengineers at the University of California, Davis.

Protein study suggests drug side effects are inevitable

May 20, 2013

A new study of both computer-created and natural proteins suggests that the number of unique pockets – sites where small molecule pharmaceutical compounds can bind to proteins – is surprisingly small, meaning drug side ...

Attacking MRSA with metals from antibacterial clays

May 17, 2013

In the race to protect society from infectious microbes, the bugs are outrunning us. The need for new therapeutic agents is acute, given the emergence of novel pathogens as well as old foes bearing heightened antibiotic resistance.

User comments : 0

More news stories

New method for producing clean hydrogen

Duke University engineers have developed a novel method for producing clean hydrogen, which could prove essential to weaning society off of fossil fuels and their environmental implications.

Protein study suggests drug side effects are inevitable

A new study of both computer-created and natural proteins suggests that the number of unique pockets – sites where small molecule pharmaceutical compounds can bind to proteins – is surprisingly small, meaning drug side ...

Beautiful 'flowers' self-assemble in a beaker

By simply manipulating chemical gradients in a beaker of fluid, materials scientists at Harvard have found that they can control the growth behavior of crystals to create precisely tailored structures—such ...

Attacking MRSA with metals from antibacterial clays

In the race to protect society from infectious microbes, the bugs are outrunning us. The need for new therapeutic agents is acute, given the emergence of novel pathogens as well as old foes bearing heightened antibiotic resistance.

Encouraging signs for bee biodiversity

Declines in the biodiversity of pollinating insects and wild plants have slowed in recent years, according to a new study. Researchers led by the University of Leeds and the Naturalis Biodiversity Centre in the Netherlands ...

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...